285 related articles for article (PubMed ID: 33477997)
21. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
[TBL] [Abstract][Full Text] [Related]
22. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
[TBL] [Abstract][Full Text] [Related]
23. Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29.
Bartolini G; Ammar K; Mantovani B; Scanabissi F; Ferreri AM; Rocchi P; Orlandi M
Anticancer Res; 2004; 24(3a):1779-83. PubMed ID: 15274355
[TBL] [Abstract][Full Text] [Related]
24. Bis-indols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells.
Pisano C; Kollar P; Gianní M; Kalac Y; Giordano V; Ferrara FF; Tancredi R; Devoto A; Rinaldi A; Rambaldi A; Penco S; Marzi M; Moretti G; Vesci L; Tinti O; Carminati P; Terao M; Garattini E
Blood; 2002 Nov; 100(10):3719-30. PubMed ID: 12393712
[TBL] [Abstract][Full Text] [Related]
25. Synthetic Diphenylacetylene-Based Retinoids Induce DNA Damage in Chinese Hamster Ovary Cells without Altering Viability.
Hudhud L; Chisholm DR; Whiting A; Steib A; Pohóczky K; Kecskés A; Szőke É; Helyes Z
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164242
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of synthetic retinoid derivatives as inducers of stem cell differentiation.
Christie VB; Barnard JH; Batsanov AS; Bridgens CE; Cartmell EB; Collings JC; Maltman DJ; Redfern CP; Marder TB; Przyborski S; Whiting A
Org Biomol Chem; 2008 Oct; 6(19):3497-507. PubMed ID: 19082150
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro.
Lin LM; Li BX; Xiao JB; Lin DH; Yang BF
World J Gastroenterol; 2005 Sep; 11(36):5633-7. PubMed ID: 16237756
[TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437.
Sun SY; Yue P; Shroot B; Hong WK; Lotan R
J Cell Physiol; 1997 Nov; 173(2):279-84. PubMed ID: 9365537
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
[TBL] [Abstract][Full Text] [Related]
31. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
[TBL] [Abstract][Full Text] [Related]
32. [Synthesis of retinoids with a modified polar group and their antitumor activity. Report I].
Deriabina EL; Khodonov AA; Cherevataia GV; Kirillova IuG; Shvets VI; Kostanian IA; Astapova MV; Dranitsyna SM; Starovoĭtova EV
Bioorg Khim; 1995 Dec; 21(12):941-9. PubMed ID: 8602891
[TBL] [Abstract][Full Text] [Related]
33. The peptidomimetic, 1-adamantyl-substituted, and flex-het classes of retinoid-derived molecules: structure-activity relationships and retinoid receptor-independent anticancer activities.
Dawson MI; Fontana JA
Mini Rev Med Chem; 2010 Jun; 10(6):455-91. PubMed ID: 20370709
[TBL] [Abstract][Full Text] [Related]
34. Chalcone derivatives cause accumulation of colon cancer cells in the G2/M phase and induce apoptosis.
Kello M; Drutovic D; Pilatova MB; Tischlerova V; Perjesi P; Mojzis J
Life Sci; 2016 Apr; 150():32-8. PubMed ID: 26916824
[TBL] [Abstract][Full Text] [Related]
35. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells.
Desai SH; Boskovic G; Eastham L; Dawson M; Niles RM
Biochem Pharmacol; 2000 May; 59(10):1265-75. PubMed ID: 10736427
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid receptor alpha mediates growth inhibition by retinoids in human colon carcinoma HT29 cells.
Nicke B; Kaiser A; Wiedenmann B; Riecken EO; Rosewicz S
Biochem Biophys Res Commun; 1999 Aug; 261(3):572-7. PubMed ID: 10441468
[TBL] [Abstract][Full Text] [Related]
37. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells.
Huang Q; Wang L; Ran Q; Wang J; Wang C; He H; Li L; Qi H
Drug Des Devel Ther; 2019; 13():1927-1940. PubMed ID: 31239643
[No Abstract] [Full Text] [Related]
38. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
Tobita T; Takeshita A; Kitamura K; Ohnishi K; Yanagi M; Hiraoka A; Karasuno T; Takeuchi M; Miyawaki S; Ueda R; Naoe T; Ohno R
Blood; 1997 Aug; 90(3):967-73. PubMed ID: 9242525
[TBL] [Abstract][Full Text] [Related]
39. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
40. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation.
Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T
Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
